⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENLV News
Enlivex Therapeutics Ltd. Ordinary Shares
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
globenewswire.com
ENLV
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
globenewswire.com
ENLV
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt
globenewswire.com
ENLV
Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48
globenewswire.com
ENLV
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program
globenewswire.com
ENLV
Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
globenewswire.com
ENLV
Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
OTH
ENLV
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
globenewswire.com
ENLV
RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance
accessnewswire.com
OWLS
BGL
MMA
ENLV
IPST
RedChip Spotlights the Future of Finance at Fintech & Digital Asset Treasury Strategy (DATS) Virtual Investor Conference on February 4
accessnewswire.com
OWLS
BGL
MMA
ENLV